Ian Hagemann, Md, PhD

Medical School Department Pathology and Immunology
Research Program Solid Tumor Therapeutics
Ian Hagemann

Researcher Background

Primary Academic Title

Professor, Department of Pathology and Immunology, WashU Medicine

Training

  • 2008 - 2011: Resident in Anatomic Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2010 - 2011: Chief Resident, Anatomic Pathology , Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2011 - 2012: Fellow in Selective (Surgical) Pathology, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
  • 2012 - 2013: Fellow in Molecular Genetic Pathology, Washington University, St. Louis, MO

Education

  • 2008: MD, Washington University School of Medicine, St. Louis, MO
  • 2008: PhD, Washington University School of Medicine, St. Louis, MO

Research & Select Publications

Research Interest

Clinical and translational research on the gentic and epigenetic basis of gynecologic cancers

Research publications

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Authors:

Kong T, Mabry A, Highkin M, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Ma CX

Journal & Year:

Nat Commun • 2026

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.
Authors:

Davis AA, Jaeger E, Hagemann IS, one or more additional authors omitted Cristofanilli M

Journal & Year:

Clin Cancer Res • 2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Mullen MM

Journal & Year:

J Clin Invest • 2025

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Authors:

Zhang X, Goedegebuure SP, Chen MY, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Gillanders WE

Journal & Year:

Genome Med • 2024

Tumour evolution and microenvironment interactions in 2D and 3D space.
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Ding L

Journal & Year:

Nature • 2024